We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Short-Term Use of PICCs Holds Certain Risk

By HospiMedica International staff writers
Posted on 14 Mar 2018
A new study concludes that although short-term use of peripherally inserted central catheters (PICCs) is common, it does not warrant the potential hazards they pose.

Researchers at the University of Michigan (U-M; Ann Arbor, USA), Henry Ford Hospital (Detroit, MI, USA), and other institutions collected data from the medical records of 15,397 adults who received PICCs during their hospitalization in order to identify patient, provider, and device characteristics, and investigate clinical outcomes associated with short-term PICCs. More...
The study was conducted between January 2014 and June 2016, with patients prospectively followed until PICC removal, death, or 70 days after insertion.

The results revealed that 25.3% had a PICC dwell time of up to five days, with most short-term PICCs removed during hospitalization. Compared to PICCs placed for longer than five days, variables related with short-term PICCs included difficult venous access, multi-lumen devices, and teaching hospitals. Among those with short-term PICCs, 9.6% experienced a complication, including 2.5% that experienced venous thromboembolism (VTE), and 0.4% that experienced a central line associated bloodstream infection (CLABSI) event. The most common minor complications were catheter occlusion (4%) and tip migration (2.2%). The study was published in the February 2018 issue of Hospital Medicine.

“When PICCs first came out, they became an 'easy button' for vascular access, and the safety issues weren't recognized. The use of PICCs exploded because the safety issues were not initially recognized, including those associated with clots and infections,” said lead author David Paje, MD, MPH, of U-M. “We're coming back full circle, and we need to adapt and implement quality improvement processes to be more judicious with their use. We need to recognize that PICCs are not without any consequence, even for short-term use.”

PICCs have become the preferred device through which to administer long-term intravenous (IV) fluids, antibiotics, and other drugs because they have lower risks of infection, can be conveniently placed at the bedside, and can stay in place for long periods of time. The ability to keep PICCs in for weeks or even months also allows patients who need a constant flow of medications to go home with these catheters.

Related Links:
University of Michigan
Henry Ford Hospital

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.